Fatigue, health-related quality-of-life and metabolic changes in men treated with enzalutamide or abiraterone acetate plus prednisone for metastatic castration-resistant prostate cancer: A randomised clinical trial (HEAT).
暂无分享,去创建一个
G. Palapattu | R. Bisbjerg | J. Faber | J. Sønksen | C. Kistorp | M. Fode | H. Lindberg | T. Klausen | K. Ternov | P. B. Østergren